Patients with recurrent or metastatic squamous cell carcinoma (HNSCC), who had markers showing they would likely respond to ...
A phase 2 trial evaluated the combination of neoadjuvant pembrolizumab and accelerated methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy in patients with nonurothelial bladder cancers ...
Comparing metagenomic profiles of the skin microbiome in immunosuppressed patients and those at high and low risk for cutaneous squamous cell carcinoma (SCC) revealed distinct expansions in fungal and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback